Literature DB >> 4030570

Effects of histamine on bronchial artery blood flow and bronchomotor tone.

W M Long, C L Sprung, H el Fawal, L D Yerger, P Eyre, W M Abraham, A Wanner.   

Abstract

The effects of aerosolized 5% histamine (10 breaths) on bronchial artery blood flow (Qbr), airflow resistance (RL), and pulmonary and systemic hemodynamics were studied in mechanically ventilated sheep anesthetized with pentobarbital sodium. Histamine increased mean Qbr and RL to 252 +/- 45 and 337 +/- 53% of base line, respectively. This effect was significantly different from base line for 30 min after challenge. The histamine-induced increase in RL was blocked by pretreatment with the histamine H1 receptor antagonist, chlorpheniramine, whereas the histamine-induced elevation in Qbr was prevented by the H2 antagonist, metiamide. Both responses were blocked only when both antagonists were present. Changes in Qbr were not directly associated with alterations in systemic and pulmonary hemodynamics or arterial blood gas composition. In vitro histamine caused a dose-dependent contraction of ovine bronchial artery strips that was prevented by H1 antagonist. The H2 agonist, impromidine, caused relaxation of precontracted arterial strips and was more potent and efficacious than histamine, whereas H1 agonists failed to elicit a relaxant response. Thus these findings indicate that histamine aerosol induces a vasodilation in the bronchial vascular bed; histamine has a direct effect on Qbr that is independent of alterations in RL, systemic and pulmonary hemodynamics, or arterial blood gas composition; and, histamine-induced bronchoconstriction is mediated predominantly by H1-receptors, whereas increased Qbr is controlled predominantly by H2-receptors, probably located in resistance vessels. This local effect of histamine on Qbr may have important implications in the pathophysiology of bronchial asthma and pulmonary edema.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4030570     DOI: 10.1152/jappl.1985.59.1.254

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  11 in total

1.  Inhaled histamine increases the rate of absorption of sodium cromoglycate from the lung.

Authors:  R Richards; C Fowler; S Simpson; A G Renwick; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

2.  Intrapulmonary bronchial blood flow of rats as studied by the microsphere method.

Authors:  M Nakai; M Sasaki; S Okubo; T Yoshioka; T Kunieda
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

Review 3.  A friend to the airways: a review of the emerging clinical importance of the bronchial arterial circulation.

Authors:  Stephen Osiro; Christopher Wear; Ryan Hudson; Xiao-Xiao Ma; Anna Zurada; Maciej Michalak; Marios Loukas
Journal:  Surg Radiol Anat       Date:  2012-05-03       Impact factor: 1.246

Review 4.  Pharmacological studies of pulmonary anaphylaxis in vitro: a review.

Authors:  P O Ogunbiyi; P Eyre
Journal:  Agents Actions       Date:  1985-12

5.  H1- and H2-receptor characterization in the tracheal circulation of sheep.

Authors:  S E Webber; R O Salonen; J G Widdicombe
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

6.  Functional adaptations of the bronchial circulation.

Authors:  H Baier
Journal:  Lung       Date:  1986       Impact factor: 2.584

7.  Dose-related effects of pharmacological mediators on tracheal vascular resistance in dogs.

Authors:  L A Laitinen; M A Laitinen; J G Widdicombe
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

8.  Effect of histamine on human bronchial arteries in vitro.

Authors:  S F Liu; M Yacoub; P J Barnes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

Review 9.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

Review 10.  The airway microvasculature and exercise induced asthma.

Authors:  S D Anderson; E Daviskas
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.